Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EVO Worldwide is a private healthcare technology and medical device company focused on molecular breast imaging for women with dense breasts. The company operates through its subsidiary SmartBreast, which manufactures, markets, and distributes molecular breast imaging systems including the EVE CLEAR SCAN e750 and e680. EVO Worldwide has been described as the global distributor for these systems and has historical ties to development of the Asia-Pacific market for GE's NM750b breast imaging platform. Its business is centered on secondary screening and diagnostic imaging rather than therapeutics, with a focus on improving breast cancer detection where mammography has limitations. The company appears to be a small private organization with operations linked to the United States and Taiwan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EVO Worldwide.